Sotera Health (NASDAQ:SHC – Free Report) had its price objective increased by Barclays from $17.00 to $19.00 in a research note released on Wednesday morning, Benzinga reports. They currently have an overweight rating on the stock. Several other equities research analysts have also commented on the company. KeyCorp began coverage on Sotera Health in a […]